DTE vs MRNA
DTE (DTE) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
DTE (DTE) common stock.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
DTE does not have a complete income-statement cache yet.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
DTE currently screens at market cap $0. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DTE and MRNA stock pages for the full models.
Not investment advice.